002030 达安基因
午间休市 02-10 11:30:00
资讯
新帖
简况
达安基因:截至2026年1月30日,公司股东总户数约为17万户
证券之星 · 02-03
达安基因:截至2026年1月30日,公司股东总户数约为17万户
股市必读:达安基因(002030)预计2025年全年归属净利润亏损6.07亿元至8.65亿元
证券之星 · 02-02
股市必读:达安基因(002030)预计2025年全年归属净利润亏损6.07亿元至8.65亿元
达安基因(002030)披露关于2025年度发放员工现金激励奖金池留存奖金的议案,1月30日股价下跌3.93%
证券之星 · 01-30
达安基因(002030)披露关于2025年度发放员工现金激励奖金池留存奖金的议案,1月30日股价下跌3.93%
1月29日达安基因(002030)龙虎榜数据:机构净卖出1365.18万元,北向资金净买入634.15万元
证券之星 · 01-29
1月29日达安基因(002030)龙虎榜数据:机构净卖出1365.18万元,北向资金净买入634.15万元
异动快报:达安基因(002030)1月29日14点3分触及跌停板
证券之星 · 01-29
异动快报:达安基因(002030)1月29日14点3分触及跌停板
达安基因最新公告:目前经营情况正常不存在应披露而未披露的重大事项
证券之星 · 01-27
达安基因最新公告:目前经营情况正常不存在应披露而未披露的重大事项
1月27日达安基因(002030)龙虎榜数据:北向资金净卖出3368.92万元(3日)
证券之星 · 01-27
1月27日达安基因(002030)龙虎榜数据:北向资金净卖出3368.92万元(3日)
异动快报:达安基因(002030)1月27日10点29分触及涨停板
中金财经 · 01-27
异动快报:达安基因(002030)1月27日10点29分触及涨停板
流感板块盘初上扬,达安基因涨停
经济观察网 · 01-26
流感板块盘初上扬,达安基因涨停
达安基因:对赛隽生物1类生物药无强制披露义务
证券之星 · 01-16
达安基因:对赛隽生物1类生物药无强制披露义务
达安基因(002030)12月31日股东户数13.2万户,较上期减少2.22%
证券之星 · 01-14
达安基因(002030)12月31日股东户数13.2万户,较上期减少2.22%
达安基因:赛隽生物未纳入公司合并报表范围
证券之星 · 01-14
达安基因:赛隽生物未纳入公司合并报表范围
达安基因(002030)12月31日股东户数13.2万户,较上期减少2.22%
证券之星 · 01-07
达安基因(002030)12月31日股东户数13.2万户,较上期减少2.22%
达安基因:截至2025年11月28日股东总户数约为13万5千户
证券之星 · 2025-12-23
达安基因:截至2025年11月28日股东总户数约为13万5千户
达安基因(002030)11月28日股东户数13.5万户,较上期减少2.88%
证券之星 · 2025-12-15
达安基因(002030)11月28日股东户数13.5万户,较上期减少2.88%
达安基因:公司目前暂无相关计划
中金财经 · 2025-12-09
达安基因:公司目前暂无相关计划
达安基因(002030)11月28日股东户数13.5万户,较上期减少2.88%
证券之星 · 2025-12-02
达安基因(002030)11月28日股东户数13.5万户,较上期减少2.88%
意大利埃尼公司将尼日利亚深水区OML 118区块股份提升至15%
投资观察 · 2025-11-25
意大利埃尼公司将尼日利亚深水区OML 118区块股份提升至15%
达安基因:截至2025年10月31日股东总户数约为13万9千户
证券之星 · 2025-11-21
达安基因:截至2025年10月31日股东总户数约为13万9千户
达安基因最新公告:间接控股股东拟变更为广药集团
证券之星 · 2025-11-17
达安基因最新公告:间接控股股东拟变更为广药集团
加载更多
公司概况
公司名称:
广州达安基因股份有限公司
所属行业:
医药制造业
上市日期:
2004-08-09
主营业务:
广州达安基因股份有限公司的主营业务是以分子诊断技术为主导的,集临床检验试剂、仪器和配套耗材的研发、生产、销售。公司的主要产品是荧光定量PCR系列产品(临床)、化学发光系列、时间分辨系列产品、酶联免疫系列产品、胶体金系列产品、生化系列产品、质谱系列产品、POCT系列产品、仪器与软件类产品、荧光分析系列产品、免疫层析系列产品、微柱凝胶系列产品、荧光原位杂交产品、样本采集系列产品、核酸提取系列产品、检测服务产品、科研服务产品。
发行价格:
7.30
{"stockData":{"symbol":"002030","market":"SZ","secType":"STK","nameCN":"达安基因","latestPrice":6.52,"timestamp":1770696894000,"preClose":6.55,"halted":0,"volume":17933581,"delay":0,"changeRate":-0.0046,"floatShares":1403000000,"shares":1403000000,"eps":-0.4019,"marketStatus":"午间休市","change":-0.03,"latestTime":"02-10 11:30:00","open":6.55,"high":6.55,"low":6.48,"amount":117000000,"amplitude":0.0107,"askPrice":6.53,"askSize":1086,"bidPrice":6.52,"bidSize":305,"shortable":0,"etf":0,"ttmEps":-0.4019,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770699600000},"marketStatusCode":3,"adr":0,"adjPreClose":6.55,"symbolType":"stock","openAndCloseTimeList":[[1770687000000,1770694200000],[1770699600000,1770706800000]],"highLimit":7.21,"lowLimit":5.9,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1403446032,"isCdr":false,"pbRate":1.19,"roa":"--","roe":"--","epsLYR":-0.66,"committee":0.218032,"marketValue":9150000000,"turnoverRate":0.0128,"status":1,"floatMarketCap":9150000000},"requestUrl":"/m/hq/s/002030","defaultTab":"news","newsList":[{"id":"2608843197","title":"达安基因:截至2026年1月30日,公司股东总户数约为17万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608843197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608843197?lang=zh_cn&edition=full","pubTime":"2026-02-03 11:35","pubTimestamp":1770089732,"startTime":"0","endTime":"0","summary":"证券之星消息,达安基因(002030)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问:请问1月31日公司股东人数是多少?谢谢!达安基因回复:投资者您好,感谢您对达安基因的关注。截至2026年1月30日,公司股东总户数约为17万户。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300016258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0122","BK0046","002030","BK0168","BK0239","BK0028","BK0188","BK0159"],"gpt_icon":0},{"id":"2608886201","title":"股市必读:达安基因(002030)预计2025年全年归属净利润亏损6.07亿元至8.65亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608886201","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608886201?lang=zh_cn&edition=full","pubTime":"2026-02-02 02:51","pubTimestamp":1769971868,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,达安基因报收于6.6元,下跌3.93%,换手率8.09%,成交量113.58万手,成交额7.66亿元。业绩披露要点业绩预告达安基因发布业绩预告,预计2025年全年归属净利润亏损6.07亿元至8.65亿元。公司公告汇总2025年年度业绩预告广州达安基因股份有限公司预计2025年度归属于上市公司股东的净利润为-86,500.00万元至-60,700.00万元,较上年同期有所增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030"],"gpt_icon":0},{"id":"2607346044","title":"达安基因(002030)披露关于2025年度发放员工现金激励奖金池留存奖金的议案,1月30日股价下跌3.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607346044","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607346044?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:48","pubTimestamp":1769784496,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘,达安基因报收于6.6元,较前一交易日下跌3.93%,最新总市值为92.63亿元。近日,广州达安基因股份有限公司召开第九届董事会2026年第一次临时会议,审议通过《关于2025年度发放员工现金激励奖金池留存奖金的议案》。会议同意从2020年至2022年累积留存的员工现金激励奖金池余额中提取不超过2,600万元,用于2025年度对公司业绩目标达成有直接影响的员工的绩效奖金。董事会授权管理层制定具体发放细则,薪酬与考核委员会负责监督执行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0168","BK0028","BK0122","BK0042","002030","BK0239","BK0159"],"gpt_icon":0},{"id":"2607707407","title":"1月29日达安基因(002030)龙虎榜数据:机构净卖出1365.18万元,北向资金净买入634.15万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607707407","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607707407?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:36","pubTimestamp":1769679365,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月29日公布的交易公开信息显示,达安基因因日跌幅偏离值达到7%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年1月29日收盘,达安基因报收于6.87元,下跌9.96%,跌停,换手率12.64%,成交量177.37万手,成交额12.38亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出1365.18万元,北向资金合计净买入634.15万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900029718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0122","BK0159","BK0028","BK0188","BK0168","002030","BK0042"],"gpt_icon":0},{"id":"2607777252","title":"异动快报:达安基因(002030)1月29日14点3分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2607777252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607777252?lang=zh_cn&edition=full","pubTime":"2026-01-29 14:05","pubTimestamp":1769666726,"startTime":"0","endTime":"0","summary":"证券之星1月29日盘中消息,14点3分达安基因(002030)触及跌停板。其所属行业医疗器械目前下跌。领涨股为奕瑞科技。该股为养老产业,人工智能,AI医疗概念热股,当日养老产业概念上涨0.13%。1月28日的资金流向数据方面,主力资金净流出8581.04万元,占总成交额3.87%,游资资金净流入340.83万元,占总成交额0.15%,散户资金净流入8240.21万元,占总成交额3.71%。近5日资金流向一览见下表:达安基因主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900018913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0122","BK0159","BK0188","BK0042","002030","BK0168","BK0028","BK0239"],"gpt_icon":0},{"id":"2606783415","title":"达安基因最新公告:目前经营情况正常不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2606783415","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606783415?lang=zh_cn&edition=full","pubTime":"2026-01-27 19:00","pubTimestamp":1769511650,"startTime":"0","endTime":"0","summary":"经核实,公司前期披露的信息不存在需要更正、补充之处,近期经营情况正常,内外部经营环境未发生重大变化。除间接控股股东广州金融控股集团有限公司、广州生物医药与健康产业投资有限公司与广州医药集团有限公司签署了《关于广州达安基因股份有限公司控股权收购框架协议》外,公司、控股股东和间接控股股东不存在应披露而未披露的重大事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700034237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","002030","BK0188","BK0042","BK0159","BK0028","BK0239","BK0046","BK0168"],"gpt_icon":0},{"id":"2606202087","title":"1月27日达安基因(002030)龙虎榜数据:北向资金净卖出3368.92万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606202087","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606202087?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:33","pubTimestamp":1769506424,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月27日公布的交易公开信息显示,达安基因因连续三个交易日内,涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年1月27日收盘,达安基因报收于7.71元,上涨9.99%,已连续涨停2天,换手率19.35%,成交量271.53万手,成交额20.71亿元。从龙虎榜公布的三日买卖数据来看,北向资金合计净卖出3368.92万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700029761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0046","BK0028","BK0122","BK0159","002030","BK0188","BK0239","BK0042"],"gpt_icon":0},{"id":"2606459279","title":"异动快报:达安基因(002030)1月27日10点29分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2606459279","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606459279?lang=zh_cn&edition=full","pubTime":"2026-01-27 11:03","pubTimestamp":1769482984,"startTime":"0","endTime":"0","summary":"证券之星1月27日盘中消息,10点29分达安基因(002030)触及涨停板。其所属行业医疗器械目前下跌。领涨股为凯普生物。该股为尼帕病毒,人工智能,肝炎概念概念热股,当日尼帕病毒概念上涨3.5%。1月26日的资金流向数据方面,主力资金净流入1.5亿元,占总成交额42.22%,游资资金净流出7199.42万元,占总成交额20.2%,散户资金净流出7845.37万元,占总成交额22.02%。近5日资金流向一览见下表: 达安基因主要指标及行业内排名如下: 为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/27/20260127130001.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/27/20260127130001.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260127/31975132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0046","002030","BK0042","BK0122","BK0028","BK0188","BK0159","BK0168","BK0239"],"gpt_icon":0},{"id":"2606267520","title":"流感板块盘初上扬,达安基因涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2606267520","media":"经济观察网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606267520?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:43","pubTimestamp":1769391780,"startTime":"0","endTime":"0","summary":"经济观察网 流感板块盘初上扬,达安基因涨停,迈克生物、之江生物涨超10%,万孚生物、华兰疫苗跟涨。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-01-26/doc-inhiqxez8304112.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-01-26/doc-inhiqxez8304112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0122","BK0168","BK0042","BK0046","002030","BK0159","BK0188","BK0239","BK0028"],"gpt_icon":0},{"id":"2603093726","title":"达安基因:对赛隽生物1类生物药无强制披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2603093726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603093726?lang=zh_cn&edition=full","pubTime":"2026-01-16 09:00","pubTimestamp":1768525256,"startTime":"0","endTime":"0","summary":"证券之星消息,达安基因01月15日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘你好,赛隽生物作为公司的合营子公司,是否有法律义务披露其1类生物药披露的相关信息?反而2025年12月31日股东人数应该随年报披露而披露,提前披露年报数据,为什么?公司对广州赛隽生物科技有限公司的1类生物药无强制披露义务。后续如有对此类披露规则的明确要求,公司也会依照执行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600006259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002030","BK0042","BK0122","159839","BK0159","BK0168","BK0028","BK0188","BK0046"],"gpt_icon":0},{"id":"2603251699","title":"达安基因(002030)12月31日股东户数13.2万户,较上期减少2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603251699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603251699?lang=zh_cn&edition=full","pubTime":"2026-01-14 17:26","pubTimestamp":1768382771,"startTime":"0","endTime":"0","summary":"证券之星消息,近日达安基因披露,截至2025年12月31日公司股东户数为13.2万户,较11月28日减少3000.0户,减幅为2.22%。在医疗器械行业个股中,达安基因股东户数高于行业平均水平,截至12月31日,医疗器械行业平均股东户数为2.2万户。从股价来看,2025年11月28日至2025年12月31日,达安基因区间跌幅为9.28%,在此期间股东户数减少3000.0户,减幅为2.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400029298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","BK0046","002030","BK0159","BK0188","BK0168","BK0028","BK0042"],"gpt_icon":0},{"id":"2603663437","title":"达安基因:赛隽生物未纳入公司合并报表范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2603663437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603663437?lang=zh_cn&edition=full","pubTime":"2026-01-14 11:33","pubTimestamp":1768361586,"startTime":"0","endTime":"0","summary":"证券之星消息,达安基因(002030)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问:按照公司披露的年报,赛隽生物是公司的合营公司,其近期创新药获批公司不做公告,为什么?达安基因回复:投资者您好,感谢您对达安基因的关注。公司历来披露全资及控股子公司获得三类医疗器械注册证的情况。广州赛隽生物科技有限公司是公司控股子公司广州市达瑞生物技术股份有限公司的合营企业,未纳入公司合并报表范围。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400015726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0168","BK0042","BK0046","002030","BK0159","BK0188","BK0239","BK0028"],"gpt_icon":0},{"id":"2601764138","title":"达安基因(002030)12月31日股东户数13.2万户,较上期减少2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601764138","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601764138?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:33","pubTimestamp":1767778403,"startTime":"0","endTime":"0","summary":"证券之星消息,近日达安基因披露,截至2025年12月31日公司股东户数为13.2万户,较11月28日减少3000.0户,减幅为2.22%。在医疗器械行业个股中,达安基因股东户数高于行业平均水平,截至12月31日,医疗器械行业平均股东户数为2.2万户。从股价来看,2025年11月28日至2025年12月31日,达安基因区间跌幅为9.28%,在此期间股东户数减少3000.0户,减幅为2.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700027061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0122","BK0042","BK0046","002030","BK0168","BK0028","BK0239","BK0159"],"gpt_icon":0},{"id":"2593548044","title":"达安基因:截至2025年11月28日股东总户数约为13万5千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593548044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593548044?lang=zh_cn&edition=full","pubTime":"2025-12-23 08:48","pubTimestamp":1766450892,"startTime":"0","endTime":"0","summary":"证券之星消息,达安基因(002030)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好:请问截止12月19公司日人数是多少,谢谢股东达安基因回复:投资者您好,感谢您对达安基因的关注。公司仅提供每月月末股东人数,截至2025年11月28日,公司股东总户数约为13万5千户。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300006169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0159","BK0046","BK0239","BK0122","002030","BK0042","BK0028","BK0168","BK0188"],"gpt_icon":0},{"id":"2591161248","title":"达安基因(002030)11月28日股东户数13.5万户,较上期减少2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591161248","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591161248?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:44","pubTimestamp":1765791884,"startTime":"0","endTime":"0","summary":"证券之星消息,近日达安基因披露,截至2025年11月28日公司股东户数为13.5万户,较10月31日减少4000.0户,减幅为2.88%。在医疗器械行业个股中,达安基因股东户数高于行业平均水平,截至11月28日,医疗器械行业平均股东户数为2.19万户。从股价来看,2025年10月31日至2025年11月28日,达安基因区间涨幅为0.77%,在此期间股东户数减少4000.0户,减幅为2.88%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0239","002030","BK0168","BK0188","BK0028","BK0042","BK0046","BK0159"],"gpt_icon":0},{"id":"2590311634","title":"达安基因:公司目前暂无相关计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2590311634","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590311634?lang=zh_cn&edition=full","pubTime":"2025-12-09 17:12","pubTimestamp":1765271530,"startTime":"0","endTime":"0","summary":"证券之星消息,达安基因(002030)12月09日在投资者关系平台上答复投资者关心的问题。投资者提问:当前证监会鼓励上市公司并购,目前公司持有安杰思15%的股份,安杰思每年有近3亿的净利润,如果与之并购,使之财务报表合并对公司将产生积极的效果,请问公司有没有这一方面的考虑?谢谢!达安基因回复:投资者您好,感谢您对达安基因的关注和建议。公司目前暂无相关计划。谢谢!为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251209/31853498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0046","BK0028","002030","BK0188","BK0159","BK0122","BK0239","BK0168","BK0042"],"gpt_icon":0},{"id":"2588003937","title":"达安基因(002030)11月28日股东户数13.5万户,较上期减少2.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588003937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588003937?lang=zh_cn&edition=full","pubTime":"2025-12-02 17:43","pubTimestamp":1764668612,"startTime":"0","endTime":"0","summary":"证券之星消息,近日达安基因披露,截至2025年11月28日公司股东户数为13.5万户,较10月31日减少4000.0户,减幅为2.88%。在医疗器械行业个股中,达安基因股东户数高于行业平均水平,截至11月28日,医疗器械行业平均股东户数为2.2万户。从股价来看,2025年10月31日至2025年11月28日,达安基因区间涨幅为0.77%,在此期间股东户数减少4000.0户,减幅为2.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200026426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0159","BK0046","BK0239","BK0122","002030","BK0042","BK0028","BK0168","BK0188"],"gpt_icon":0},{"id":"1192428920","title":"意大利埃尼公司将尼日利亚深水区OML 118区块股份提升至15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1192428920","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192428920?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:18","pubTimestamp":1764058734,"startTime":"0","endTime":"0","summary":"11月25日 - 埃尼公司宣布,从TotalEnergies EP Nigeria Limited收购了额外2.5%的OML 118生产分享合同(PSC)股份,行使其优先购买权。此次交易已获得必要的监管审批,使其在OML 118 PSC的股份从12.5%增加至15%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0046","BK0042","002030","BK0188","BK0159","BK0168","BK0028","BK0122","BK0239"],"gpt_icon":0},{"id":"2585118725","title":"达安基因:截至2025年10月31日股东总户数约为13万9千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585118725","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585118725?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:27","pubTimestamp":1763713636,"startTime":"0","endTime":"0","summary":"证券之星消息,达安基因(002030)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问截至2025年11月20日,公司的股东人数是多少?谢谢。达安基因回复:投资者您好,感谢您对达安基因的关注。公司仅提供每月月末股东人数,截至2025年10月31日,公司股东总户数约为13万9千户。谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100020190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0159","002030","BK0168","BK0188","BK0046","BK0028","BK0239","BK0122","BK0042"],"gpt_icon":0},{"id":"2584237636","title":"达安基因最新公告:间接控股股东拟变更为广药集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2584237636","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584237636?lang=zh_cn&edition=full","pubTime":"2025-11-17 20:51","pubTimestamp":1763383874,"startTime":"0","endTime":"0","summary":"若本次股权转让和本次协议转让实施完成,广药集团将合计控制公司26.63%股份,进而成为公司的间接控股股东。本次交易若成功实施,不会导致公司控股股东及实际控制人发生变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700033592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002030","BK0042","BK0122","BK0028","BK0188","BK0159","BK0168","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770696910114,"stockEarnings":[{"period":"1week","weight":0.0331},{"period":"1month","weight":0.0299},{"period":"3month","weight":-0.0253},{"period":"6month","weight":-0.0722},{"period":"1year","weight":0.1491},{"period":"ytd","weight":0.099}],"compareEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0301},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.248},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州达安基因股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"170000人(较上一季度增加28.79%)","perCapita":"32529股","listingDate":"2004-08-09","address":"广东省广州市黄埔区高新技术开发区科学城香山路19号","registeredCapital":"140344万元","survey":" 广州达安基因股份有限公司的主营业务是以分子诊断技术为主导的,集临床检验试剂、仪器和配套耗材的研发、生产、销售。公司的主要产品是荧光定量PCR系列产品(临床)、化学发光系列、时间分辨系列产品、酶联免疫系列产品、胶体金系列产品、生化系列产品、质谱系列产品、POCT系列产品、仪器与软件类产品、荧光分析系列产品、免疫层析系列产品、微柱凝胶系列产品、荧光原位杂交产品、样本采集系列产品、核酸提取系列产品、检测服务产品、科研服务产品。","listedPrice":7.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达安基因,002030,达安基因股票,达安基因股票老虎,达安基因股票老虎国际,达安基因行情,达安基因股票行情,达安基因股价,达安基因股市,达安基因股票价格,达安基因股票交易,达安基因股票购买,达安基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}